Follow the HilleVax, Inc. stock price and the full directors' dealings record of the company, a listed issuer based in United States. Shares trade on US US, under the oversight of SEC (Form 4). Operating in the Technology sector, HilleVax, Inc. has recorded 35 reports. Market capitalisation: €1,107bn. The latest transaction was disclosed on 17 September 2025 (U). Among the most active insiders: Kohli Aditya. The full history is accessible without an account.
35
Insider Decl.
0
Thresholds
€138,042
2 ops.
Buy Volume
€2m
18 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate HilleVax, Inc. Strong Buy (bullish), based on 40 analysts. Average price target: US$828.73.
45Σ signal
Buys €138,042€2m Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 9,719 of 26,211 companies
58.2
score / 100
Value
38
Quality
78
FCF yld0.2%
Earn yld0.8%
EV/EBITDA·
ROE40%
Gross mgn40%
Net mgn23%
Debt/EBITDA0.8x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.